hemophilia
Hemophilia is divided into two types: A and B. Hemophilia A is a bleeding disease caused by the deficiency of coagulation factor VIII, accounting for about 85% of congenital bleeding diseases. According to the report of the joint meeting of the World Health Organization (WHO) and the World Federation of Hemophilia (WHF) in 1990, the incidence of hemophilia A is about 15-20/100,000 people. According to statistics from European and American countries, it is about 5-10/100,000 people. The incidence of hemophilia A in China is about 3-4/100,000 people. Hemophilia B, also known as factor IX deficiency or Christmas disease, has an incidence of about 1.0-1.5/105, accounting for 15%-20% of hemophilia. The gene of factor IX is 34kb long, located on the long arm of chromosome X, with 8 exons and 7 introns. Factor IX is a plasma protein dependent on vitamin K, with a relative molecular weight of 56,000, and is synthesized in the liver. The treatment of hemophilia A and B is similar, using replacement therapy, and plasma, prothrombin complex concentrate (PCC), factor IX concentrate and recombinant factor IX products can be used.
-
Site of disease:
Spinal cord blood vessels -
Infectious :
Not contagious -
Frequent population:
Often develops in childhood -
Related symptoms:
Skin bleeding spots Intra-articular bleeding Muscle bleeding Wounds that do not heal after tooth extraction Joint swelling -
Concurrent disease:
Related Drugs
Ozagrel Sodium for Injection
Indication: It is suitable for the treatment of acute thrombotic cerebral infarction and movement disorders associated with cerebral infarction.
Manufacturer:
Dandong Yichuang Pharmaceutical Co., Ltd.
Painkillers
Indication: This product is used for mild to moderate pain caused by colds, such as fever, joint pain, neuralgia, headache, migraine, dysmenorrhea, etc. It is especially suitable for people who are allergic to aspirin or are not suitable for aspirin (such as patients with chickenpox, hemophilia, bleeding diseases, anticoagulant therapy, and patients with peptic ulcer, gastritis, etc.).
Xue Ning Granules
Manufacturer:
China Resources 39 (Beijing) Pharmaceutical Co., Ltd.
Tranexamic acid capsules
Indication: This product is mainly used for various bleeding caused by acute or chronic, localized or systemic primary hyperfibrinolysis. For secondary hyperfibrinolytic state caused by disseminated intravascular coagulation, this product should be used with caution before heparinization. This product is also suitable for ① trauma or surgical bleeding in organs rich in plasminogen activators such as the prostate, urethra, lungs, brain, uterus, adrenal glands, thyroid glands, and liver; ② used as an antagonist of tissue plasminogen activator (tPA), streptokinase, and urokinase; ③ fibrinolytic bleeding caused by artificial abortion, early placental abruption, stillbirth, and amniotic fluid embolism; ④ menorrhagia, hyphema, and severe epistaxis due to local increased fibrinolysis; ⑤ used to prevent or alleviate tooth extraction or
Tranexamic acid capsules
Indication: This product is mainly used for various bleeding caused by acute or chronic, localized or systemic primary hyperfibrinolysis. For secondary hyperfibrinolytic state caused by disseminated intravascular coagulation, this product should be used with caution before heparinization. This product is also suitable for ① trauma or surgical bleeding in organs rich in plasminogen activators such as the prostate, urethra, lungs, brain, uterus, adrenal glands, thyroid glands, and liver; ② used as an antagonist of tissue plasminogen activator (tPA), streptokinase, and urokinase; ③ fibrinolytic bleeding caused by artificial abortion, early placental abruption, stillbirth, and amniotic fluid embolism; ④ menorrhagia, hyphema, and severe epistaxis due to local increased fibrinolysis; ⑤ used to prevent or alleviate tooth extraction or
Aminocaproic acid tablets
Indication: It is suitable for the prevention and treatment of various bleeding caused by hyperfibrinolysis. (1) Bleeding caused by trauma or surgery of organs rich in plasminogen activators such as the prostate, urethra, lungs, liver, pancreas, brain, uterus, adrenal glands, and thyroid glands, and bleeding caused by excessive amounts of tissue plasminogen activator (t-PA), streptokinase, or urokinase. (2) It can be used as an adjuvant treatment for bleeding after tooth extraction or oral surgery or menorrhagia in hemophiliacs. (3) It can be used for symptomatic treatment of various bleeding such as upper gastrointestinal bleeding, hemoptysis, idiopathic thrombocytopenic purpura, and leukemia. It has a significant effect on general chronic oozing; it has a poor effect on bleeding caused by abnormal coagulation function; and it has no hemostatic effect on severe bleeding, massive bleeding from wounds, and bleeding from cancer.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Aminocaproic acid tablets
Indication: It is suitable for the prevention and treatment of various bleeding caused by hyperfibrinolysis. (1) Bleeding caused by trauma or surgery of organs rich in plasminogen activators such as the prostate, urethra, lungs, liver, pancreas, brain, uterus, adrenal glands, and thyroid glands, and bleeding caused by excessive amounts of tissue plasminogen activator (t-PA), streptokinase, or urokinase. (2) It can be used as an adjuvant treatment for bleeding after tooth extraction or oral surgery or menorrhagia in hemophiliacs. (3) It can be used for symptomatic treatment of various bleeding such as upper gastrointestinal bleeding, hemoptysis, idiopathic thrombocytopenic purpura, and leukemia. It has a significant effect on general chronic oozing; it has a poor effect on bleeding caused by abnormal coagulation function; and it has no hemostatic effect on severe bleeding, massive bleeding from wounds, and bleeding from cancer.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Aminocaproic acid tablets
Indication: It is suitable for the prevention and treatment of various bleeding caused by hyperfibrinolysis. (1) Bleeding caused by trauma or surgery of organs rich in plasminogen activators such as the prostate, urethra, lungs, liver, pancreas, brain, uterus, adrenal glands, and thyroid glands, and bleeding caused by excessive amounts of tissue plasminogen activator (t-PA), streptokinase, or urokinase. (2) It can be used as an adjuvant treatment for bleeding after tooth extraction or oral surgery or menorrhagia in hemophiliacs. (3) It can be used for symptomatic treatment of various bleeding such as upper gastrointestinal bleeding, hemoptysis, idiopathic thrombocytopenic purpura, and leukemia. It has a significant effect on general chronic oozing; it has a poor effect on bleeding caused by abnormal coagulation function; and it has no hemostatic effect on severe bleeding, massive bleeding from wounds, and bleeding from cancer.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Aminocaproic acid tablets
Indication: It is suitable for the prevention and treatment of various bleeding caused by hyperfibrinolysis. (1) Bleeding caused by trauma or surgery of organs rich in plasminogen activators such as the prostate, urethra, lungs, liver, pancreas, brain, uterus, adrenal glands, and thyroid glands, and bleeding caused by excessive amounts of tissue plasminogen activator (t-PA), streptokinase, or urokinase. (2) It can be used as an adjuvant treatment for bleeding after tooth extraction or oral surgery or menorrhagia in hemophiliacs. (3) It can be used for symptomatic treatment of various bleeding such as upper gastrointestinal bleeding, hemoptysis, idiopathic thrombocytopenic purpura, and leukemia. It has a significant effect on general chronic oozing; it has a poor effect on bleeding caused by abnormal coagulation function; and it has no hemostatic effect on severe bleeding, massive bleeding from wounds, and bleeding from cancer.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Related Ingredients
-
Ozagrel sodium list
189224-26-8 -
Phenacetin list
62-44-2 -
Chrysophanic acid list
481-74-3 -
Tranexamic acid list
701-54-2 -
6-Aminocaproic acid list
60-32-2